Clinical data
Other names
F-0930-RS
Identifiers
1-Benzyl-2-piperazin-1-yl-1H-benzimidazole
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
C18H20N4
292.386 g·mol−1
InChI=1S/C18H20N4/c1-2-6-15(7-3-1)14-22-17-9-5-4-8-16(17)20-18(22)21-12-10-19-11-13-21/h1-9,19H,10-14H2 Y
Key:PWWDCRQZITYKDV-UHFFFAOYSA-N Y
Lerisetron (code name F-0930-RS) is a drug which acts as an antagonist at the 5-HT3 receptor.[1] It is a potent antiemetic[2][3] and was in clinical trials for the treatment of nausea associated with cancer chemotherapy.[4]
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.